Development of artemisinin resistance in malaria therapy
J Nass, T Efferth - Pharmacological Research, 2019 - Elsevier
Malaria affects 200 million people worldwide. Today, the most successful treatments are
artemisinin-based combination therapies (ACT). Resistance has already been described for …
artemisinin-based combination therapies (ACT). Resistance has already been described for …
Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali
K Traoré, SAS Diakité, S Bah, DS Konaté, D Dabitao… - Drugs in R&D, 2020 - Springer
Abstract Background In 2006, the National Malaria Control Program in Mali recommended
artemisinin-based combination therapy as the first-line treatment for uncomplicated malaria …
artemisinin-based combination therapy as the first-line treatment for uncomplicated malaria …
Molecular assays for determining sulphadoxine-pyrimethamine drug resistance in India: a systematic review
S Bhullar, N Mishra - Parasitology Research, 2022 - Springer
A plethora of studies analyse the molecular markers of drug resistance and hence help in
guiding the evidence-based malaria treatment policies in India. For reporting mutations, a …
guiding the evidence-based malaria treatment policies in India. For reporting mutations, a …
[HTML][HTML] Absence of Biomakers of Resistance in K13 Propeller Gene of Plasmodium falciparum from Gombe LGA of Gombe State, Nigeria
I Muhammad, PM Sale, AL Midala - Advances, 2022 - advancesj.org
Malaria is still one of the life threatening parasitic disease in Sub-Saharan Africa. The
causative agent of the disease always provide a means of avoiding the action of most …
causative agent of the disease always provide a means of avoiding the action of most …
Susceptibility of Plasmodium falciparum isolates to antimalarial drugs in a highly seasonal malaria endemic village in Mali
K Traoré, SAS Diakité, S Bah, DS Konaté, D Dabitao… - 2019 - researchsquare.com
Background: In 2006, the National Malaria Control Program (NMCP) in Mali recommended
artemisinin-based combination therapy (ACT) as the first-line treatment for uncomplicated …
artemisinin-based combination therapy (ACT) as the first-line treatment for uncomplicated …
[PDF][PDF] A Novel, Improved Throughput Bioassay for Determining the Relative Speed of Antimalarial Drug Action using Fluorescent Vitality Probes
D Laming - 2020 - core.ac.uk
Malaria is one of the most prevalent diseases in Africa and Plasmodium falciparum is widely
accepted as the most virulent of the malaria parasite species, with a fatality rate of 15–20 …
accepted as the most virulent of the malaria parasite species, with a fatality rate of 15–20 …
Malaria management in animal model using antioxidant vitamins.
BN Esimai, OO Njoku… - Nigerian Journal of …, 2020 - search.ebscohost.com
Management of malaria has become a major public health problem with the emergence of
Plasmodium falciparum resistant malaria to most antimalaria drugs. The work was employed …
Plasmodium falciparum resistant malaria to most antimalaria drugs. The work was employed …